Craig Lipset, MPH
Mr. Lipset is Head of Clinical Innovation within Worldwide Research & Development at Pfizer. Craig’s team is managing initiatives and investments that impact development of the Pfizer portfolio today while collectively redefining the future of clinical research. Craig previously served as Venture Partner in Pfizer Venture Investments (Pfizer’s VC arm), where he focused on diversifying the company’s $50M annual budget for private investments in the areas of diagnostics and health technology. Craig was also Senior Director in Molecular Medicine, where he spearheaded initiatives driving innovation in clinical research and personalized medicine by drawing upon tools from health information technology, telemedicine, and eHealth. Craig brings over 15 years of leadership and innovation in the field of drug development. He previously served as Associate Vice President of Program Management at Adnexus Therapeutics (acquired by Bristol-Myers Squibb), and on the founding management team for Perceptive Informatics (now part of PAREXEL International). Listed among the 2010 PharmaVOICE most inspiring people in the life sciences and among Pharmaceutical Executive’s 2011 Emerging Leaders, Craig was recently named program chair for the 2012 Annual Meeting of the Drug Information Association. Outside of Pfizer, Craig serves on the Board of Directors for the Foundation for Sarcoidosis Research and as a Mentor at health tech accelerator Blueprint Health.